You are here

• Home
• Therapy Areas
• Cardiovascular

• Randomized, Open, 4-way Crossover, Single Center, Phase I Relative Bioavailability Study in Type 2 Diabetes Mellitus Patients to Measure the Extent and Rate of Absorption of AZD1656 From Different Tablet Formulations

Disease

diabetes type 2

Drug Name

AZD1656

Generic Name

AZD1656

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

I

Start Date

Sep 28, 2010

Study Name

D1020C00033

Study Id

D1020C00033

ClinicalTrials.gov ID

NCT01221519

Recruiting Status

Closed

Protocol Status

Not Available

Report

Oct 24, 2011

• D1020C00033.pdf (144 KB)

Page tools

• Print
• Bookmark this page